MAMAOPE MEDICALS
Organization Details
The MamaOpe is a non-invasive device designed to complement the assessment skills of clinicians during the detection of vital signs of respiratory infections. It uses acoustic sensors placed over strategic lung fields, to record, analyze and display the final outcomes of breathing patterns in a 1-minute period. Our solution has been trained and validated by specialists (during a clinical performance evaluation in over 160 children in Uganda) to detect and highlight abnormalities across a spectrum of lung illnesses. This enables early and accurate disease diagnosis helping to facilitate timely intervention hence improving healthcare outcomes which contributes to SDG 3.
Impact Story
Early diagnosis of Acute Respiratory Infections (ARIs) is vital for improved treatment outcomes. However, most clinicians fail to correctly determine and interpret the signs and symptoms for the diagnosis of ARIs due to clinical skills deficits among frontline health workers. Furthermore, the available current tools are subjective and manual leading to errors and more diagnosis time. These inaccuracies result in misdiagnosis, delayed access to treatment, and complications including death. The death toll in 2020 due to ARIs in children aged below 5 was over 800,000 (16% of all child deaths).
We designed the MamaOpe device, a non-evasive diagnostic tool that automates the monitoring of respiratory rate and indicative lung sounds during auscultation. The device is strapped around the chest with acoustic sensors placed over strategic lung fields to measure the breathing rate and detect lung sounds. Its clinical decision support functionality provides instant feedback, to support the care provider in determining a correct diagnosis, based on the WHO IMCI guidelines. This empowers clinicians to diagnose more patients, more accurately in less time at a lower cost hence facilitating early treatment initiation, and design of implementation programs aimed at reducing global mortality attributable to ARIs.
